FDA OKs 2-Drug Combo Treatment for Advanced Melanoma
FRIDAY, Jan. 10, 2014 (HealthDay News) — The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines “are the first drugs approved for combination treatment of melanoma,” Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products … Read more